Karolinska Development AB (publ) (KDEV.ST)

SEK 1.07

(3.5%)

Eps Summary of Karolinska Development AB (publ)

  • Karolinska Development AB (publ)'s latest annual eps in 2023 was 0.02 SEK , up 103.57% from previous year.
  • Karolinska Development AB (publ)'s latest quarterly eps in 2024 Q2 was -0.06 SEK , down -7512.5% from previous quarter.
  • Karolinska Development AB (publ) reported an annual eps of -0.56 SEK in 2022, down -131.28% from previous year.
  • Karolinska Development AB (publ) reported an annual eps of 1.79 SEK in 2021, up 191.79% from previous year.
  • Karolinska Development AB (publ) reported a quarterly eps of -0.06 SEK for 2024 Q2, down -7512.5% from previous quarter.
  • Karolinska Development AB (publ) reported a quarterly eps of N/A for 2023 FY, up 103.57% from previous quarter.

Annual Eps Chart of Karolinska Development AB (publ) (2023 - 2008)

Historical Annual Eps of Karolinska Development AB (publ) (2023 - 2008)

Year Eps Eps Growth
2023 0.02 SEK 103.57%
2022 -0.56 SEK -131.28%
2021 1.79 SEK 191.79%
2020 -1.95 SEK -124.75%
2019 7.88 SEK 1776.19%
2018 0.42 SEK -83.78%
2017 2.59 SEK 171.75%
2016 -3.61 SEK 79.45%
2015 -17.57 SEK -156.5%
2014 -6.85 SEK -137.85%
2013 -2.88 SEK 25.77%
2012 -3.88 SEK 50.13%
2011 -7.78 SEK 12.68%
2010 -8.91 SEK -10188.68%
2009 -0.09 SEK 58.76%
2008 -0.21 SEK 0.0%

Peer Eps Comparison of Karolinska Development AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 103.636%
Ziccum AB (publ) -1.54 SEK 101.299%
Modus Therapeutics Holding AB (publ) -1.01 SEK 101.98%
BioArctic AB (publ) 2.60 SEK 99.231%
Sprint Bioscience AB (publ) -0.01 SEK 417.46%
Mendus AB (publ) -4.40 SEK 100.455%
Genovis AB (publ.) 0.94 SEK 97.872%
Intervacc AB (publ) -1.69 SEK 101.183%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK 109.091%
Active Biotech AB (publ) -0.17 SEK 111.765%
Magle Chemoswed Holding AB (publ) 1.13 SEK 98.23%
Bio-Works Technologies AB (publ) -1.57 SEK 101.274%
Aptahem AB (publ) -0.05 SEK 141.408%
Vicore Pharma Holding AB (publ) -3.22 SEK 100.621%
Kancera AB (publ) -0.80 SEK 102.5%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 100.201%
Fluicell AB (publ) -0.24 SEK 108.333%
Saniona AB (publ) -1.29 SEK 101.55%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK 110.526%
Biovica International AB (publ) -2.14 SEK 100.935%
Spago Nanomedical AB (publ) -0.43 SEK 104.651%
AcouSort AB (publ) -1.29 SEK 101.55%
Xintela AB (publ) -0.13 SEK 115.385%
Abliva AB (publ) -0.09 SEK 122.124%
Egetis Therapeutics AB (publ) -1.27 SEK 101.575%
OncoZenge AB (publ) -1.36 SEK 101.471%
Amniotics AB (publ) -0.01 SEK 281.818%
2cureX AB (publ) -1.85 SEK 101.081%
CombiGene AB (publ) -1.80 SEK 101.111%
Asarina Pharma AB (publ) -0.57 SEK 103.509%
Calliditas Therapeutics AB (publ) -8.69 SEK 100.23%
Camurus AB (publ) 7.78 SEK 99.743%
Corline Biomedical AB -0.08 SEK 123.753%
IRLAB Therapeutics AB (publ) -3.43 SEK 100.583%
Isofol Medical AB (publ) -0.23 SEK 108.696%
I-Tech AB 1.70 SEK 98.824%
Hansa Biopharma AB (publ) -15.83 SEK 100.126%
Cyxone AB (publ) -0.22 SEK 109.091%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 101.01%
Biosergen AB -0.60 SEK 103.333%
Cantargia AB (publ) -1.65 SEK 101.212%
NextCell Pharma AB -1.03 SEK 101.942%
Xspray Pharma AB (publ) -6.76 SEK 100.296%
Elicera Therapeutics AB (publ) -0.83 SEK 102.41%
Nanologica AB (publ) -2.05 SEK 100.976%
SynAct Pharma AB -6.64 SEK 100.301%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 107.692%
Stayble Therapeutics AB (publ) -0.92 SEK 102.174%
LIDDS AB (publ) -0.63 SEK 103.175%
Lipum AB (publ) -4.45 SEK 100.449%
BioInvent International AB (publ) -5.02 SEK 100.398%
Alzinova AB (publ) -0.41 SEK 104.878%
Oncopeptides AB (publ) -1.96 SEK 101.02%
Pila Pharma AB (publ) -0.47 SEK 104.255%
Guard Therapeutics International AB (publ) -11.26 SEK 100.178%
Scandinavian ChemoTech AB (publ) -1.13 SEK 101.77%
Simris Alg AB (publ) -0.16 SEK 112.5%
Diamyd Medical AB (publ) -1.60 SEK 101.25%
Xbrane Biopharma AB (publ) -1.27 SEK 101.575%
Ascelia Pharma AB (publ) -3.24 SEK 100.617%
Diagonal Bio AB (publ) -0.32 SEK 106.25%